[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"therapy\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:therapy":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,10,0,[8,45,75,104,129,156,183,210,240,265],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":29,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":44},"100644204","phase-3-comparison-of-early-pleural-irrigation-strategy-with-saline-to-the-standard-of-care-for-the-management-of-complicated-pleural-infections-100644204",false,"NCT07666464","Comparison of Early Pleural Irrigation Strategy With Saline to the Standard of Care for the Management of Complicated Pleural Infections.","Randomized Controlled Trial Comparing an Early Pleural Irrigation Strategy With Saline to the Standard of Care for the Management of Complicated Pleural Infections.","EPISSOC","Inclusion Criteria:\n\n* Adults (≥18 years old) capable of fully understanding the study;\n* Complicated pleural infection (macroscopically purulent fluid, positive for bacteria on Gram's staining, positive on culture for bacterial infection, loculated effusion, pH \\\u003C7.2, great abundance) leading to thoracic drainage;\n* Initial ultrasound evaluation to estimate pleural fluid abundance and detect fibrinous septation;\n* Social security affiliation\n* Written informed consent\n* Highly effective contraceptive methods for women of childbearing age include: Combined hormonal contraception (estrogen and progestogen) associated with inhibition of ovulation (oral, intravaginal, transdermal); progestogen-only hormonal contraception associated with inhibition of ovulation (oral, injectable, implantable); intrauterine device; hormone- releasing intrauterine system; bilateral occlusion of the Fallopian tubes; vasectomized partner; sexual abstinence\n\nExclusion Criteria:\n\n* Tuberculous pleural effusions;\n* Previous treatment with intrapleural fibrinolytic agents (urokinase, streptokinase, alteplase, or DNase) or intrapleural saline lavage;\n* Previous thoracic surgery for pleural infection;\n* Contraindications to auxiliary treatments, to fibrinolysis or surgery as well as to procedures such as drainage and lavage;\n* Pregnancy or lactation;\n* Expected survival of less than 3 months;\n* Thoracic drainage since more than 24h;\n* Patient deprived of liberty by administrative or judicial decision or placed under judicial protection (guardianship or supervision);\n* Inability to give informed written consent;\n* Participation in another clinical trial;\n* Patient being a relative of the investigator or any member of the team directly involved in the study, including assistant physicians, pharmacists, nurses, and coordinators","ALL","18 Years",{"count":20,"type":21},244,"ESTIMATED","INTERVENTIONAL",[24],"PHASE3","Intrapleural enzyme therapy (IET) is regarded by recent guidelines as a \"rescue\" therapy for managing complicated pleural infections; however, it is associated with significant side effects, including pleural bleeding, pain, and fever. Pleural irrigation with saline may serve as an alternative, yet evidence supporting its effectiveness is limited to a single small- scale, single-center randomized trial. The objective of the study is to compare the risk of treatment failure at 30 days (defined as a composite outcome that includes death, the need for thoracic surgery, or additional intrapleural enzyme therapy) between an early pleural irrigation strategy and standard care for complicated pleural infections.",[27,28],"Therapy","Pleural Infections",[30,31],"therapy","pleural infections","RECRUITING","2026-06-30",{"date":35,"type":36},"2026-07-01","ACTUAL",{"date":38,"type":36},"2026-05-13",{"date":40,"type":21},"2029-08",{"name":42,"class":43},"Centre Hospitalier Universitaire, Amiens","OTHER",1,{"id":46,"slug":47,"hasResults":11,"nctId":48,"briefTitle":49,"officialTitle":49,"acronym":50,"eligibilityCriteria":51,"healthyVolunteers":11,"sex":17,"minAge":4,"maxAge":4,"enrollmentInfo":52,"targetDuration":54,"studyType":55,"phases":4,"briefSummary":56,"conditions":57,"keywords":60,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":66,"lastUpdatePostDateStruct":67,"startDateStruct":69,"completionDateStruct":71,"leadSponsor":73,"locationsCount":44},"100604871","argentine-registry-of-crohns-disease-and-ulcerative-colitis-100604871","NCT07155148","Argentine Registry of Crohn's Disease and Ulcerative Colitis","RADECCU","Inclusion Criteria:\n\n* Any patient diagnosed with IBD defined by validated diagnostic criteria can be included into the registry. The criteria for IBD diagnosis were based on previously published criteria for IBD diagnosis, including clinical, endoscopic, laboratory, and histopathological aspects, as well as small bowel imaging studies\n\nExclusion Criteria:\n\n* Suspected IBD diagnosis without confirmation\n* IBD patients with incomplete information about therapy and follow-up",{"count":53,"type":21},4250,"3 Years","OBSERVATIONAL","RADECCU is a strictly observational IBD registry in Argentina. The registry is open to all practicing gastroenterologist in the country grouped within the Argentinean Crohn's and Ulcerative Colitis Group (GADECCU). The registry will include outcomes of routine clinical practice of patients with IBD including the pediatric and adult population.",[58,59,27],"Epidemiology","Inflammatory Bowel Disease (IBD)",[61,62,63,64,65],"Crohn's Disease","Ulcerative Colitis","Argentina","Registry","Inflammatory Bowel Disease","2025-09-20",{"date":68,"type":36},"2025-09-23",{"date":70,"type":36},"2023-07-14",{"date":72,"type":21},"2027-12-30",{"name":74,"class":43},"Grupo Argentino de Enfermedad de Crohn y Colitis Ulcerosa",{"id":76,"slug":77,"hasResults":11,"nctId":78,"briefTitle":79,"officialTitle":80,"acronym":4,"eligibilityCriteria":81,"healthyVolunteers":11,"sex":17,"minAge":82,"maxAge":83,"enrollmentInfo":84,"targetDuration":4,"studyType":22,"phases":86,"briefSummary":88,"conditions":89,"keywords":91,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":95,"lastUpdatePostDateStruct":96,"startDateStruct":98,"completionDateStruct":100,"leadSponsor":102,"locationsCount":44},"100508525","strategies-for-toddler-asd-with-remote-therapy-star-model-for-asd-100508525","NCT05901558","Strategies for Toddler ASD With Remote-therapy (STAR) Model for ASD","Strategies for Toddler ASD With Remote-therapy (STAR) Model for Early ASD Toddlers: a Randomized Trial","Inclusion Criteria:\n\n* Children screened as positive for ASD.\n* Two-tiered screening process combing Level 1(The Modified Checklist for Autism in Toddlers-Revised\u002FFollow-Up , M-CHAT-R\u002FF) and Level 2 (The Screening Tool for Autism in Toddlers and Young Children, STAT)\n\nExclusion Criteria:\n\n* Other neurologic or degenerative diseases;\n* Severe hearing or visual impairment;\n* Genetic anomaly which may affect impact on intervention;\n* Not available for regular intervention and follow-up.","16 Months","30 Months",{"count":85,"type":21},110,[87],"NA","The project aims to develop and implement the Strategies for Toddler Autism spectrum disorder(ASD) with Remote-therapy (STAR) model for early toddlers with ASD in local community sites in Shanghai. It's a randomized control trial lasting 3 years. The children will be divided into 2 groups, one for STAR intervention group and the other for community intervention group. The STAR intervention group will be performed STAR other than community intervention.",[90,27],"Autism Spectrum Disorder",[92,93,94],"Autism","Naturalistic developmental behavioral intervetion","Intervention","2025-09-03",{"date":97,"type":36},"2025-09-05",{"date":99,"type":36},"2023-06-15",{"date":101,"type":21},"2026-12-30",{"name":103,"class":43},"Children's Hospital of Fudan University",{"id":105,"slug":106,"hasResults":11,"nctId":107,"briefTitle":108,"officialTitle":108,"acronym":4,"eligibilityCriteria":109,"healthyVolunteers":11,"sex":17,"minAge":54,"maxAge":110,"enrollmentInfo":111,"targetDuration":4,"studyType":22,"phases":113,"briefSummary":115,"conditions":116,"keywords":4,"overallStatus":119,"whyStopped":4,"lastUpdateSubmitDate":120,"lastUpdatePostDateStruct":121,"startDateStruct":123,"completionDateStruct":125,"leadSponsor":127,"locationsCount":44},"100599069","phase-2-investigating-the-therapeutic-efficacy-of-all-trans-retinoic-acid-in-autism-spectrum-disorder-patients-with-15q11-13-duplication-syndrome-100599069","NCT07079696","Investigating the Therapeutic Efficacy of All-trans Retinoic Acid in Autism Spectrum Disorder Patients With 15q11-13 Duplication Syndrome","Inclusion Criteria:\n\n1. Clinical Diagnosis Conducted by two experienced physicians based on Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition （DSM-V）\n2. Diagnostic Scale Assessment Performed by professionally certified examiners using ADOS-2\n3. Genetic Testing Diagnostic criteria via genomic analysis : detection of 15q11-13 duplication containing UBE3A\n\nExclusion Criteria:\n\n1. History of acute or chronic infection within the past 3 months\n2. Active epileptic seizures within the past 6 months\n3. Intake of nutritional supplements (e.g., vitamin A and\u002For minerals) within the past 1 month\n4. History of chronic diseases, including abnormal liver function, abnormal renal function, or thyroid dysfunction","7 Years",{"count":112,"type":21},90,[114],"PHASE2","Autism spectrum disorder (ASD) , hereafter referred to as autism, is a group of neurodevelopmental disorders caused by genetic and environmental factors. Its core symptoms are social impairment, repetitive stereotyped behaviors, and restricted interests.\n\nThe 15q11-13 region of the human chromosome is a locus prone to structural abnormalities leading to neurological disorders. Maternal duplications within this region lead to Dup15q syndrome , which accounts for approximately 1% of ASD cases .\n\nThis region harbors multiple alleles, and current research indicates that the pathophysiological alterations in this syndrome primarily involve UBE3A . Among all genes in the 15q11-13 region, only UBE3A exhibits cell-type-specific maternal monoallelic expression . Consequently, duplication of the UBE3A gene is considered the primary pathogenic factor in the pathology of Dup15q syndrome.\n\nStudies show that the metabolic conversion of retinol to retinoic acid is impaired in ASD patients with UBE3A overexpression and corresponding animal models . Notably, dietary supplementation with all-trans retinoic acid (ATRA) has been shown to significantly ameliorate autism-like behaviors caused by UBE3A overexpression in male mice .\n\nThis study aims to evaluate ATRA treatment in children with Dup15q syndrome-related autism , assessing changes in their ADOS-2 scores , to potentially provide a novel therapeutic approach for autism treatment.",[117,90,27,118],"Dup15q Syndrome","All-trans Retinoic Acid","NOT_YET_RECRUITING","2025-07-14",{"date":122,"type":36},"2025-07-23",{"date":124,"type":21},"2025-09-01",{"date":126,"type":21},"2027-01",{"name":128,"class":43},"Second Affiliated Hospital, School of Medicine, Zhejiang University",{"id":130,"slug":131,"hasResults":11,"nctId":132,"briefTitle":133,"officialTitle":134,"acronym":4,"eligibilityCriteria":135,"healthyVolunteers":136,"sex":137,"minAge":18,"maxAge":138,"enrollmentInfo":139,"targetDuration":4,"studyType":22,"phases":141,"briefSummary":142,"conditions":143,"keywords":4,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":147,"lastUpdatePostDateStruct":148,"startDateStruct":150,"completionDateStruct":152,"leadSponsor":154,"locationsCount":44},"100582526","breastfeeding-relaxation-intervention-among-mothers-of-preterm-infants-in-hospital-sultan-abdul-aziz-shah-hsaas-100582526","NCT06864455","Breastfeeding Relaxation Intervention Among Mothers of Preterm Infants in Hospital Sultan Abdul Aziz Shah (HSAAS)","\"Effects of a Relaxation Intervention on Physiological and Psychological Outcomes Among Mothers of Preterm Infants At Hospital Sultan Abdul Aziz Shah : a Within-subject Randomized Trials\"","Inclusion Criteria ( Mothers)\n\n* Malaysian women of reproductive age (18-49 years)\n* Muslim\n* Non-smoker\n* Understand English or Malay\n* Currently breastfeed their infants\n* Mothers of infants born in gestational age (28 weeks- 35 weeks)\n* No medical conditions that can affect infant feeding.\n\nExclusion Criteria:\n\n* Taking psychiatric medication and being diagnosed with mental illness.\n* Mothers are on medication that contradicts breastfeeding (eg: under medication HIV\u002FAIDS)\n* Plan to formula feed or mix feeding their infants.\n* Mothers of infants with illness that could affect breastfeeding and growth (respiratory issues, gastrointestinal issues, feeding difficulties, neurological disorder, etc)",true,"FEMALE","49 Years",{"count":140,"type":21},15,[87],"This study is designed to compare the effects of four relaxation interventions on both physiological and psychological outcomes in lactating mothers of preterm infants. The interventions being tested include:\n\n* Guided Imagery Meditation (GIM)\n* Religious Recitation (RR)\n* Infant Video with Music\n* Distraction with News and Media\n* A Control session\n\nThe primary objectives of the study are to evaluate and compare how these different relaxation techniques influence the physiological and psychological well-being of mothers and identify which intervention is most effective for lactating mothers who deliver prematurely.\n\nThe main research questions are:\n\n1. How do different interventions (GIM, RR, Infant Video with Music, Distraction with Media, and Control) affect physiological and psychological outcomes when measured within the same participants?\n2. Are there significant differences in physiological and psychological outcomes when participants are exposed to different interventions (GIM, RR, Infant Video with Music, Distraction with Media, and Control) within the same group?\n3. Among the interventions, which one demonstrates the most beneficial effects on physiological and psychological outcomes within the same participants?\n\nStudy Design:\n\nEach participant will be exposed to five different sessions (one for each intervention), with a gap of 1-2 days between sessions. The interventions will be administered as follows:\n\n* Guided Imagery Meditation (GIM)\n* Religious Recitation (RR)\n* Infant Video with Music\n* Distraction with News and Media\n* A Control session\n\nExpected Outcomes:\n\nThis study will assess the following physiological and psychological outcomes:\n\nPhysiological changes:\n\n* Heart Rate (HR)\n* Systolic Blood Pressure (SBP)\n* Diastolic Blood Pressure (DBP)\n* Fingertip Temperature (FT)\n* Breast milk cortisol concentration\n\nPsychological changes:\n\n•. Perceived Relaxation",[144,145,146,27],"Behaviour","Psychology","Physiology","2025-03-03",{"date":149,"type":36},"2025-03-07",{"date":151,"type":36},"2024-09-17",{"date":153,"type":21},"2026-08-21",{"name":155,"class":43},"Universiti Putra Malaysia",{"id":157,"slug":158,"hasResults":11,"nctId":159,"briefTitle":160,"officialTitle":160,"acronym":4,"eligibilityCriteria":161,"healthyVolunteers":11,"sex":17,"minAge":4,"maxAge":18,"enrollmentInfo":162,"targetDuration":164,"studyType":55,"phases":4,"briefSummary":165,"conditions":166,"keywords":170,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":174,"lastUpdatePostDateStruct":175,"startDateStruct":177,"completionDateStruct":179,"leadSponsor":181,"locationsCount":44},"100341147","infant-and-child-european-cryoablation-project-icecap-100341147","NCT03721783","Infant and Child European Cryoablation Project ICECaP","Inclusion Criteria:\n\n* all children in whom a clinical decision is made to treat with percutaneous cryoablation, to include those in whom cryoablation was not technically or clinically possible at any stage.\n\nExclusion Criteria:\n\n* none",{"count":163,"type":21},40,"2 Years","A registry to audit the current range of applications, technical success rate, safety profile, complication rate and efficacy of cryoablation procedures being performed in children.",[27,167,168,169],"Soft Tissue Lesion","Cryoablation","Pediatric",[171,172,173],"cryoablation","pediatric","registry","2024-10-24",{"date":176,"type":36},"2024-10-26",{"date":178,"type":36},"2021-06-24",{"date":180,"type":21},"2027-07-01",{"name":182,"class":43},"Great Ormond Street Hospital for Children NHS Foundation Trust",{"id":184,"slug":185,"hasResults":11,"nctId":186,"briefTitle":187,"officialTitle":188,"acronym":189,"eligibilityCriteria":190,"healthyVolunteers":11,"sex":17,"minAge":4,"maxAge":4,"enrollmentInfo":191,"targetDuration":4,"studyType":22,"phases":193,"briefSummary":194,"conditions":195,"keywords":198,"overallStatus":119,"whyStopped":4,"lastUpdateSubmitDate":202,"lastUpdatePostDateStruct":203,"startDateStruct":205,"completionDateStruct":207,"leadSponsor":208,"locationsCount":4},"100565176","functional-electrostimulation-on-the-upper-lip-in-multiple-sclerosis-100565176","NCT06638775","Functional Electrostimulation on the Upper Lip in Multiple Sclerosis","RESEARCH PROJECT on the APPLICATION of FUNCTIONAL ELECTROSTIMULATION on the UPPER LIMB in MULTIPLE SCLEROSIS","EM\u002F2024","Inclusion Criteria:\n\n* Be of legal age and sign the informed consent form.\n* Not suffer from any pathology in the upper limb such as tendinitis, oedema, fractures, etc.\n* Intact skin (no breaks, scratches, cuts, and other superficial or deep injuries) on the arm where the devices will be placed if applicable\n\nExclusion Criteria:\n\n* Severe medical problems.\n* Use of a pacemaker.\n* Pregnancy.\n* Cutaneous neuropathies.\n* Presence of other neuromuscular pathologies.",{"count":192,"type":21},30,[87],"Multiple sclerosis (MS) is an autoimmune disease where immune cells attack the body, triggering an inflammatory response. A study comparing multifield FES and conventional FES on upper extremity motor skills and functional independence in MS patients will be conducted. Results suggest that both types of FES treatments normalize muscle tone, showing superior results compared to those without FES therapy. The study aims to compare the effects of both types on MS patients.",[196,27,197],"Electrode Site Reaction","Directly Observed Therapy",[199,200,201,30],"fesia grasp","multiple sclerosis","multicampe","2024-10-10",{"date":204,"type":36},"2024-10-15",{"date":206,"type":21},"2025-01-20",{"date":66,"type":21},{"name":209,"class":43},"Universidad de Burgos",{"id":211,"slug":212,"hasResults":11,"nctId":213,"briefTitle":214,"officialTitle":214,"acronym":215,"eligibilityCriteria":216,"healthyVolunteers":11,"sex":137,"minAge":18,"maxAge":4,"enrollmentInfo":217,"targetDuration":4,"studyType":55,"phases":4,"briefSummary":218,"conditions":219,"keywords":224,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":202,"lastUpdatePostDateStruct":233,"startDateStruct":234,"completionDateStruct":236,"leadSponsor":238,"locationsCount":44},"100565235","sexual-agency-of-women-who-have-suffered-from-incests-100565235","NCT06639542","Sexual Agency of Women Who Have Suffered from Incest(s)","ASFI","Inclusion Criteria:\n\n* Age \\> 18 years old\n* Women who have suffered from incest or rape\n* Speak and understand French\n\nExclusion Criteria:\n\n* Refusal to participate\n* Non french-speakers",{"count":5,"type":21},"Case study, qualitative and exploratory approach with prospective research. This study is aimed at voluntary patients referred by the women center.\n\n* The first meeting will be the presentation of a sexo-psychomotor questionnaire, specifically made for this study. Then, if the participant is willing, the enroll for a psychomotor follow-up of 6 sessions personalized with specific objectives defined for the patient,from the questionnaire.\n* These therapy sessions can be renewed in discussion with the woman if we feel they would benefit from further follow-up. The psychomotor sessions last around 45 minutes and take place once every 15 days or 3 weeks with a variety of therapeutical techniques. This interval between sessions allows time for integration of the aspects addressed during the proposals, while ensuring continuity in the follow-up. They are aimed at developing body and emotional awareness, to help patients get to know themselves better, and experience moments in full awareness\n* End-of-follow interview with taking the questionnaire a second time, to determine, with the woman, any benefits of the \"sex-psychomotor\" care. The women will be supported in completing the questionnaire again, as they were during the initial session.",[220,221,222,223,27],"Rape Sexual Assault","Incest","Assault","Violence Against Women",[225,226,227,228,229,230,231,232],"rape","incest","violence","sexual assault","sexuality","agency","psychomotricity","psychomotor therapy",{"date":204,"type":36},{"date":235,"type":21},"2024-10-14",{"date":237,"type":21},"2025-04-20",{"name":239,"class":43},"Centre Hospitalier de Saint-Denis",{"id":241,"slug":242,"hasResults":11,"nctId":243,"briefTitle":244,"officialTitle":244,"acronym":4,"eligibilityCriteria":245,"healthyVolunteers":11,"sex":17,"minAge":4,"maxAge":4,"enrollmentInfo":246,"targetDuration":4,"studyType":55,"phases":4,"briefSummary":248,"conditions":249,"keywords":4,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":256,"lastUpdatePostDateStruct":257,"startDateStruct":259,"completionDateStruct":261,"leadSponsor":263,"locationsCount":44},"100400137","carbon-monoxide-intoxication-in-korea-prospective-cohort-care-co-cohort-100400137","NCT04490317","CARbon monoxidE intoxiCatiOn in Korea: Prospective Cohort (CARE CO Cohort)","Inclusion Criteria:\n\n* Acute CO poisoning\n\nExclusion Criteria:\n\n* Declined to enrollment in the study",{"count":247,"type":21},1500,"This prospective cohort study enrolls subjects who experience carbon monoxide (CO) poisoning. The purpose of the study is to evaluate therapeutic effects of various treatments and short and long-term outcomes in CO poisoned patients. In addition, complications of brain and heart susceptible to CO are investigated through various ways and the association between complications and the patient's prognosis is also investigated. All subjects will be regularly monitored by physicians participating in this study.",[250,251,252,253,27,254,255],"Carbon Monoxide Poisoning","Myocardial Injury","Neurologic Deficits","Image, Body","Prognostic Factors","Complications","2024-07-22",{"date":258,"type":36},"2024-07-23",{"date":260,"type":36},"2020-07-29",{"date":262,"type":21},"2035-12",{"name":264,"class":43},"Wonju Severance Christian Hospital",{"id":266,"slug":267,"hasResults":11,"nctId":268,"briefTitle":269,"officialTitle":270,"acronym":271,"eligibilityCriteria":272,"healthyVolunteers":11,"sex":17,"minAge":273,"maxAge":274,"enrollmentInfo":275,"targetDuration":4,"studyType":55,"phases":4,"briefSummary":277,"conditions":278,"keywords":4,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":287,"lastUpdatePostDateStruct":288,"startDateStruct":290,"completionDateStruct":292,"leadSponsor":294,"locationsCount":44},"100499869","invasive-group-a-streptococcal-infection-100499869","NCT05788861","Invasive Group A Streptococcal Infection","French Pediatric Nationwide Observatory of Invasive Group A Streptococcal Infection (in Childen for 0 to 18 Ages)","ISAI","Inclusion Criteria:\n\n* Age\\\u003C18 years\n* Documented invasive Group A Streptococcus infection (identification of GAS in a normally sterile site or from another site in case of toxin shock or necrotizing dermo-hypodermatitis)\n\nExclusion Criteria:\n\n* Opposition of the patient or his\u002Fher legal representative","1 Day","17 Years",{"count":276,"type":21},100,"This study is observational, retrospective and prospective study in pediatric patients hospitalized with invasive streptococcal A infection",[279,280,281,282,283,284,27,285,286],"Sepsis Due to Streptococcus, Group A","Risk Factors","Severe Infection","Medical Care","Medical Complications","Outcome, Fatal","Strain","Virulence Factors","2024-02-07",{"date":289,"type":36},"2024-02-08",{"date":291,"type":36},"2022-09-01",{"date":293,"type":21},"2026-09-01",{"name":295,"class":43},"Association Clinique Thérapeutique Infantile du val de Marne"]